Piers Gaunt, PhD (he/him/his)

Principal biostatistician
Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
Birmingham, England, United Kingdom

Presentation(s):

• Paper 69 - PRELIMINARY DOSE-VOLUME CONSTRAINTS PREDICTING SUBCUTANEOUS TISSUE FIBROSIS FOR LIMB SARCOMA USING THE VORTEX AND IMRIS TRIALS.

  Saturday, November 15, 2025
  11:00 AM - 12:00 PM EST

  Disclosure information not submitted.